BIOTECHFINANCES
Created in 1999
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
4,760 3,968Entity types
Location
12 Rue Cavenne, 69007 Lyon, France
Lyon
France
Employees
Scale: 2-10
Estimated: 9
SIREN
480764398Engaged corporates
26
8 9Added in Motherbase
4 years, 9 months ago
Media Value proposition
[Automatic translation follows] 1st weekly newsletter of specialized information, biotech, medtech, e-health, finance published by Jacques Bernard Taste
PRESENTATION
The weekly letter Biotech Finances approaches from an economic and financial angle all the questions related to the development of the biotechnology sector and more broadly of life sciences. Our target readership is mainly composed of biotechnology companies oriented towards health and the development of new therapies and new treatments for diseases, pharmaceutical companies (big pharma and other laboratories), investors, business angels, investment funds, venture capital, specialized in the biotech sector, institutions, legal advisors, development experts, and service providers and equipment suppliers. Our articles deal with research and development, new products, drugs, molecules, clinical and preclinical trials with their different phases, financing and financial practices, fundraising, capital increases, equity investments, IPOs (initial public offerings), industrial property, patents, approvals in Europe (EMEA) and the United States (FDA), partnerships, co-development, licensing (in licensing / out licensing) which allow the development and growth of biotech companies.
finance, biotech, france, SPECIALIZED PRESS, biotechnology, healthtech, medtech, pharmaceutical, medical, conference, interviews, news, investors, startups, investments, and start-upOriginal language
1er hebdomadaire d'informations spécialisées, biotech, medtech, e-santé, finances publié par Jacques Bernard Taste
PRESENTATION
La lettre hebdomadaire Biotech Finances approche sur un angle économique et financier toutes les questions liées au développement du secteur des biotechnologies et plus largement des sciences de la vie. Notre lectorat cible est composé en majeure partie d'entreprises de biotechnologies orientées sur la santé et le développement de nouvelles thérapies et de nouveaux traitement de maladies, d'entreprises pharmaceutiques (big pharma et autres laboratoires) , d'investisseurs, business angel , fonds d'investissements, capital risque, spécialisés dans le secteur des biotech, d'institutionnels, de conseils juridiques, d'experts en développement, et de fournisseurs de services et fournisseurs de matériels. Nos articles traitent de recherche et développement, de nouveaux produits, médicaments, molécules, essai clinique et préclinique avec leur différentes phases, de financements et pratiques financières, de levées de fonds, augmentation de capital, prise de participations, d'IPO (introductions en bourse) de propriété industrielle, brevets, agréements en Europe (EMEA) et aux Etats-Unis (FDA), de partenariats, co-développement, licensing (in licensing /out licensing) qui permettent l'épanouissement et la croissance des sociétés de biotech.
finance, biotech, france, PRESSE SPECIALISEE, biotechnologie, healthtech, medtech, pharmaceutique, médical, conférence, interviews, actualité, investisseurs, startups, investissements, and start-up
Biotech Finances
Biotech Finances est un média spécialisé dans l'information financière et économique de l'industrie biopharmaceutique en France et en Europe. Il fournit des analyses approfondies sur les tendances du marché, les fusions et acquisitions, les financements et les partenariats dans le secteur de la biotechnologie.
https://biotech-finances.com/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Leem Startup accelerator & VC, Pharmaceutical Manufacturing | Leem Startup accelerator & VC, Pharmaceutical Manufacturing | Other 9 Jun 2020 | | |
 France Biotech Startup accelerator & VC, Biotechnology, Biotechnology Research | France Biotech Startup accelerator & VC, Biotechnology, Biotechnology Research | Other 7 Apr 2020 7 Oct 2024 | | |
 Région Nouvelle-Aquitaine National and local authorities, Government Administration | Région Nouvelle-Aquitaine National and local authorities, Government Administration | Other 6 Oct 2016 | | |
 SATT Sud-Est Research, National and local authorities, Research Services | SATT Sud-Est Research, National and local authorities, Research Services | Other 11 Nov 2017 | | |
 Greater Paris University Hospitals - AP-HP Health, Hospitals and Health Care | Greater Paris University Hospitals - AP-HP Health, Hospitals and Health Care | Other 26 Jun 2017 24 Mar 2024 | | |
 Institut Analgesia Research, Think Tanks | Institut Analgesia Research, Think Tanks | Other 28 Sep 2015 | | |
 Eurobiomed Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Eurobiomed Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Other 23 Sep 2017 | | |
 Seventure Partners Startup accelerator & VC, Venture Capital and Private Equity Principals | Seventure Partners Startup accelerator & VC, Venture Capital and Private Equity Principals | Other 31 Mar 2018 | | |
 Linksium Venture Capital and Private Equity Principals | Linksium Venture Capital and Private Equity Principals | Other 26 Jun 2019 3 Jul 2024 | | |
 Medicen Paris Region Public business cluster, French Cluster, Civic and Social Organizations | Medicen Paris Region Public business cluster, French Cluster, Civic and Social Organizations | Other 25 Nov 2017 5 Jul 2024 | | |